Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment Biotech Investing
Bristol Myers Squibb Announces $2 Billion Incremental Share Repurchase Authorization Biotech Investing
BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles Its 2021 Forecast Biotech Investing
Risankizumab Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease Biotech Investing
Naturally Splendid Announces Meridian 8-Store Chain To Carry NATERA Plant Based Foods Biotech Investing